283 related articles for article (PubMed ID: 2789273)
21. Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
Dalal BI; Freier L; Johnston JB; Merry CC; Israels LG
Cancer; 1989 Jan; 63(1):14-22. PubMed ID: 2783375
[TBL] [Abstract][Full Text] [Related]
22. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
23. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
Spiers AS; Parekh SJ; Bishop MB
J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
26. Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Döhner H; Ho AD; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
J Natl Cancer Inst; 1993 Apr; 85(8):658-62. PubMed ID: 8468724
[TBL] [Abstract][Full Text] [Related]
27. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
28. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.
Grem JL; King SA; Cheson BD; Leyland-Jones B; Wittes RE
J Natl Cancer Inst; 1989 Mar; 81(6):448-53. PubMed ID: 2783980
[TBL] [Abstract][Full Text] [Related]
29. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
[TBL] [Abstract][Full Text] [Related]
30. Deoxycoformycin induces long-lasting remissions in hairy cell leukemia: clinical and biological results of two different regimens.
Annino L; Ferrari A; Giona F; Cimino G; Crescenzi S; Cava MC; Pacchiarotti A; Mandelli F
Leuk Lymphoma; 1994; 14 Suppl 1():115-9. PubMed ID: 7820042
[TBL] [Abstract][Full Text] [Related]
31. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
[TBL] [Abstract][Full Text] [Related]
32. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
Saven A; Piro LD
Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
[TBL] [Abstract][Full Text] [Related]
33. Complete remission in hairy cell leukaemia achieved with pentostatin.
Spiers AS; Parekh SJ
Lancet; 1984 May; 1(8385):1080-1. PubMed ID: 6144012
[No Abstract] [Full Text] [Related]
34. [Therapeutic aspects of hairy cell leukemia].
Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R
Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113
[TBL] [Abstract][Full Text] [Related]
35. Pentostatin induces durable remissions in hairy cell leukemia.
Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.
Shimoyama M; Tobinai K; Yamaguchi K; Hirashima K; Itoh S; Konishi H; Mikuni C; Togawa A; Hotta T; Toyoda N
Jpn J Clin Oncol; 1992 Dec; 22(6):406-10. PubMed ID: 1291757
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
Dutcher JP; Salva KM; Wiernik PH
Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
[TBL] [Abstract][Full Text] [Related]
38. Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.
Yamaguchi K; Yul LS; Oda T; Maeda Y; Ishii M; Fujita K; Kagiyama S; Nagai K; Suzuki H; Takatsuki K
Leuk Res; 1986; 10(8):989-93. PubMed ID: 3489140
[TBL] [Abstract][Full Text] [Related]
39. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
40. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
